Galera Therapeutics

(OTC) GRTX

Current Price$0.09

Market Cap$18.61M

Since IPO (2019)-99%

5 Year-99%

1 Year+252%

1 Month-9%

Galera Therapeutics Financials at a Glance

Market Cap

$18.61M

Revenue (TTM)

$0.00

Net Income (TTM)

$149.04M

EPS (TTM)

$1.98

P/E Ratio

0.05

Dividend

$0.00

Beta (Volatility)

0.49 (Low)

Dividend

$0.00

Beta (Volatility)

0.49 (Low)

Price

$0.09

Volume

14,309

Open

$0.10

Price

$0.09

Volume

14,309

Open

$0.10

Previous Close

$0.09

Daily Range

$0.09 - $0.10

52-Week Range

$0.02 - $0.15

Estimated Earnings Date

Aug 12, 2026

Dividend

$0.00

Beta (Volatility)

0.49 (Low)

Price

$0.09

Volume

14,309

Open

$0.10

Previous Close

$0.09

Daily Range

$0.09 - $0.10

52-Week Range

$0.02 - $0.15

Estimated Earnings Date

Aug 12, 2026

GRTX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Galera Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

John Mel Sorensen, MD

Website

www.galeratx.com

Headquarters

Malvern, PA 19355, US

GRTX Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-210.64%

Return on Capital

-92.23%

Return on Assets

2417.83%

Earnings Yield

20.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$18.61M

Shares Outstanding

203.39M

Volume

14.31K

Avg. Volume

313.97K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$5.73M

EBITDA

-$5.69M

Operating Cash Flow

-$3.00M

Capital Expenditure

$0.00

Free Cash Flow

-$3.00M

Cash & ST Invst.

$5.50M

Total Debt

$0.00

Galera Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$18.61M

N/A

Market Cap/Employee

$6.20M

N/A

Employees

N/A

Net Income

-$1.61M

-0.9%

EBITDA

-$1.66M

+15.7%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$5.50M

-17.7%

Total Debt

$0.00

-100.0%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

24.18%

N/A

Return on Invested Capital

-1.14%

N/A

Free Cash Flow

-$2.24M

+4.3%

Operating Cash Flow

-$2.24M

+4.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

VCNXVaccinex, Inc.

VCNXVaccinex, Inc.$1.02+0.00%

HESGHealth Sciences Group, Inc.

HESGHealth Sciences Group, Inc.$0.00+0.00%

NBCONeon Bloom, Inc.

NBCONeon Bloom, Inc.$0.01+0.00%

HEMPHemp, Inc

HEMPHemp, Inc$0.00+0.00%

AGTXAgentix Corp.

AGTXAgentix Corp.$0.02+0.00%

IONMAssure Holdings Corp.

IONMAssure Holdings Corp.$0.00+0.00%

MDGEFMedigene AG

MDGEFMedigene AG$2.59+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$17.92-0.01%

TAT&T

TAT&T$20.58+0.00%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.30-0.15%

CLROClearOne

CLROClearOne$6.48+1.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.35-0.05%

ONDSOndas

ONDSOndas$7.41-0.06%

SOFISoFi Technologies

SOFISoFi Technologies$18.24-0.01%

Questions About GRTX

What is the current price of Galera Therapeutics?

Galera Therapeutics is trading at $0.09 per share.

What is the 52-week range for Galera Therapeutics?

Over the past 52 weeks, Galera Therapeutics has traded between $0.02 and $0.15.

How much debt does Galera Therapeutics have?

As of the most recent reporting period, Galera Therapeutics reported total debt of $0.00.

How much cash does Galera Therapeutics have on hand?

Galera Therapeutics reported $5.50M in cash and cash equivalents in its most recent financial results.

What is Galera Therapeutics’s dividend yield?

Galera Therapeutics does not currently have a dividend yield.

Galera Therapeutics

Galera Therapeutics Financials at a Glance

GRTX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Galera Therapeutics

GRTX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Galera Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About GRTX

What is the current price of Galera Therapeutics?

What is the 52-week range for Galera Therapeutics?

How much debt does Galera Therapeutics have?

How much cash does Galera Therapeutics have on hand?

What is Galera Therapeutics’s dividend yield?

Premium Investing Services